Dr Daryll Brosanders, MD | |
Junction Navajo Route 9, Highway 371, Crownpoint, NM 87313-0358 | |
(505) 786-5291 | |
Not Available |
Full Name | Dr Daryll Brosanders |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 23 Years |
Location | Junction Navajo Route 9, Highway 371, Crownpoint, New Mexico |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144258880 | NPI | - | NPPES |
91608830 | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2004-0529 (Maryland) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
El Rio Santa Cruz Neighborhood Health Center, Inc | 6305739244 | 227 |
News Archive
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Pfizer Oncology announced today that data evaluating crizotinib in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), as well as data from Pfizer's renal cell carcinoma (RCC) portfolio on axitinib, an investigational compound, and SUTENT(sunitinib malate) will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23 - 27, 2011.
Pancreatic cancer affects approximately 46,000 people each year in the United States and ranks fourth among the leading causes of cancer-related deaths. Only about 6 percent of individuals with pancreatic cancer will live five years after their diagnosis.
› Verified 4 days ago
Entity Name | El Rio Santa Cruz Neighborhood Health Center, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487602736 PECOS PAC ID: 6305739244 Enrollment ID: O20040205000098 |
News Archive
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Pfizer Oncology announced today that data evaluating crizotinib in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), as well as data from Pfizer's renal cell carcinoma (RCC) portfolio on axitinib, an investigational compound, and SUTENT(sunitinib malate) will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23 - 27, 2011.
Pancreatic cancer affects approximately 46,000 people each year in the United States and ranks fourth among the leading causes of cancer-related deaths. Only about 6 percent of individuals with pancreatic cancer will live five years after their diagnosis.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Daryll Brosanders, MD Po Box 358, Crownpoint, NM 87313-0358 Ph: () - | Dr Daryll Brosanders, MD Junction Navajo Route 9, Highway 371, Crownpoint, NM 87313-0358 Ph: (505) 786-5291 |
News Archive
Abbott will present clinical trial results from two different interferon-free, Phase 2 studies for the treatment of hepatitis C (HCV) at the International Liver Congress 2012 (ILC 2012), the annual meeting of the European Association for the Study of the Liver (EASL), April 18-22 in Barcelona, Spain.
VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.
Pfizer Oncology announced today that data evaluating crizotinib in anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC), as well as data from Pfizer's renal cell carcinoma (RCC) portfolio on axitinib, an investigational compound, and SUTENT(sunitinib malate) will be presented at the 2011 European Multidisciplinary Cancer Congress in Stockholm, Sweden, September 23 - 27, 2011.
Pancreatic cancer affects approximately 46,000 people each year in the United States and ranks fourth among the leading causes of cancer-related deaths. Only about 6 percent of individuals with pancreatic cancer will live five years after their diagnosis.
› Verified 4 days ago
Dr. Melissa Brosanders, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: Junction Navajo Route 9, Highway 371, Crownpoint, NM 87313 Phone: 505-786-5291 Fax: 505-786-6440 | |
Dr. John J Johnson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Junction Navajo Route 9, Highway 371, Crownpoint, NM 87313 Phone: 505-786-5291 Fax: 505-786-6440 | |
Dr. Carla J Sand, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3 Navarre Blvd, Thoreau Clinic, Crownpoint, NM 87313 Phone: 505-786-5291 Fax: 505-786-6440 | |
Dr. David Josephs, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: Junction Navajo Route 9, Highway 371, Crownpoint, NM 87313 Phone: 505-786-5291 Fax: 505-786-6440 | |
Ms. Diane E Alaimo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: Junction Navajo Route 9, Highway 371, Crownpoint, NM 87313 Phone: 505-786-5291 Fax: 505-786-6440 |